Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)
Clinical trial NCT03810066 · COMPLETED
Trial details
- NCT number
- NCT03810066
- Sponsor
- University Hospital, Essen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2021-12-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.